MSB Trading 2020 - a new dawn, page-12335

I was about to say just that. ODAC was a different scenario where shareholders had the benefit of viewing the results real time. I have a gut feeling that something far far bigger is in the works. MSB is known to be a shorts playground and while all shareholders are not scientists, the reaction to the CHF readout was far from surprising. With MSB, the market loves to focus on the 5% bad (not reaching the primary endpoint) and completely disregards the good (significantly reduced mortality) excuse the percentages. What gave me confidence was the overwhelming praise during the Q & A. Only true medical experts can comprehend the gravity of the CHF results - that was enough for me. Additionally, SI's positive and forward looking statements was something like the icing on the cake.